Dyslipidemia market poised for strong growth, surpassing $29.2 bn by 2025
The strong growth will be primarily driven by the launches of three proprotein convertase subtilisin/ kexin type 9 (PCSK9)…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Diving into Digital
Pharma companies are embracing the power of digital to further their progress but there is a need for clear strategic direction to…
Impact of demonetisation on pharma industry
Amit Mookim, GM, South Asia, QuintilesIMS, explains how digital way will not only benefit the customers but also the overall…
Neurodegenerative drugs mkt set to hit $45 bn by 2022
According to GBI Research, much of the growth is expected due to the approval of many products
Complex generics: Charting a new path
A QuintilesIMS report finds that complex generics is a lucrative market for drug manufacturers, but only if they can adapt to a…
IL-17 inhibitors will drive psoriatic arthritis market to $12.6 bn by 2025: GlobalData
The relatively strong growth will primarily be driven by the increase in diagnosed prevalent cases
Asia-Pacific anti-hypertensive therapeutics market to hit $ 27 bn dollars by 2022: GBI Research
Growth will not be aided by the weak anti-hypertensive pipeline, due to lack of innovative products in late-stage development
Encouraging IPR: Pivotal to quality healthcare
Dr. Amir Ullah Khan, Visiting Professor, ISB and Director, Research, Aequitas Health Consulting cautions that access to quality…
Myelofibrosis market will exceed $1 billion by 2025
According to GlobalData, the growth will be driven by factors include an increase in the incidence of myelofibrosis, and a rise in…
Combination drugs: Easing out of existence?
Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates, gives an insight on various regulatory hurdles hindering the growth of the…
Online pharmacies: A trouble maker or game changer?
Bejon Kumar Misra, Founder, Partnership for Safe Medicines (PSM) India Initiative, feels that online pharmacies are here to stay…
Pharmacovigilance as a value addition for the pharma industry
Dr J Vijay Venkatraman, MD and CEO, Oviya MedSafe and Karunakaran Shanmugam, QA Associate, Oviya MedSafe,advocate implementing…
How Ind AS impacts pharma businesses?
Sumit Seth, Partner, Price Waterhouse & Co explains how the introduction of the new accounting standards will impact the…
How to effectively address the issue of unaffordable drug pricing in India?
Abhishek Thakur in this article tells us about how to improve overall affordability of healthcare in India
Seasonal influenza vaccines market will hit $4.3 bn by 2025
The market will grow at a compound annual growth rate of 3.3 per cent
Gastrointestinal drugs market to hit $48.4 bn dollars by 2022
Approval of new drugs, as well as rising prevalence, are expected to drive considerable growth
Major depressive disorder market will reach $5.8 bn by 2025 as awareness and drugs improve
The market will be primarily driven by the growth of atypical antipsychotics, along with the increasing global diagnosed…
Paradigm shift in consumer healthcare practices in India
As consumers are becoming more imperative, effective brand strategies to work alongside traditional pharma marketing tools that…
Pushing the boundaries of communication in pharma
Shailesh Dudani, Chief Sales Officer, Flock, an enterprise messaging app for teams gives an insight on how pharma companies can…
Start-ups and pharma industry
Poorvi Sanjanwala, Partner and Zil Shah, Associate, Rajani Associates, give an overview on the growth drivers in the pharma…